Page 1 | Search Results | Hematology, ASH Education Program

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Is there a role for low-dose DOACs as prophylaxis?

Alexander T. Cohen, Beverley J. Hunt

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 187–193.

https://doi.org/10.1182/hematology.2019000026

Published: 2019

Journal Articles

Direct oral anticoagulant monitoring: what laboratory tests are available to guide us?

Ravi Sarode

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 194–197.

https://doi.org/10.1182/hematology.2019000027

Published: 2019

Journal Articles

Anticoagulating patients with high-risk acquired thrombophilias

Leslie Skeith

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 439–449.

https://doi.org/10.1182/asheducation-2018.1.439

Published: 2018

Journal Articles

Optimizing quality care for the oral vitamin K antagonists (VKAs)

Vittorio Pengo, Gentian Denas

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 332–338.

https://doi.org/10.1182/asheducation-2018.1.332

Published: 2018

Journal Articles

Management of thrombosis in children and neonates: practical use of anticoagulants in children

Paul Monagle, Fiona Newall

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 399–404.

https://doi.org/10.1182/asheducation-2018.1.399

Published: 2018

Journal Articles

Reversing vitamin K antagonists: making the old new again

Sabine Eichinger

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 605–611.

https://doi.org/10.1182/asheducation-2016.1.605

Published: 2016

Journal Articles

Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations

Nick van Es, Harry R. Büller

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 125–131.

https://doi.org/10.1182/asheducation-2015.1.125

Published: 2015

Journal Articles

The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question

Lisa K. Hicks, Harriet Bering, Kenneth R. Carson, Judith Kleinerman, Vishal Kukreti, Alice Ma, Brigitta U. Mueller, Sarah H. O'Brien, Marcelo Pasquini, Ravindra Sarode, Lawrence Solberg, Jr, Adam E. Haynes, Mark A. Crowther

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 9–14.

https://doi.org/10.1182/asheducation-2013.1.9

Published: 2013

Journal Articles

Pros and cons of new oral anticoagulants

Kenneth A. Bauer

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 464–470.

https://doi.org/10.1182/asheducation-2013.1.464

Published: 2013

Journal Articles

Pharmacologic tools to reduce bleeding in surgery

Sam Schulman

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 517–521.

https://doi.org/10.1182/asheducation.V2012.1.517.3798536

Published: 2012

Journal Articles

Perioperative management of patients on chronic antithrombotic therapy

Thomas L. Ortel

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 529–535.

https://doi.org/10.1182/asheducation.V2012.1.529.3799663

Published: 2012

Journal Articles

Catheter-related thrombosis: lifeline or a pain in the neck?

Pieter W. Kamphuisen, Agnes Y. Y. Lee

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 638–644.

https://doi.org/10.1182/asheducation.V2012.1.638.3798656

Published: 2012

Journal Articles

Warfarin Versus New Agents: Interpreting the Data

Jack Ansell

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 221–228.

https://doi.org/10.1182/asheducation-2010.1.221

Published: 2010

Journal Articles

Duration of Anticoagulation Therapy for Venous Thromboembolism

Henri Bounameaux, Arnaud Perrier

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 252–258.

https://doi.org/10.1182/asheducation-2008.1.252

Published: 2008

Journal Articles

Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists

Francesco Dentali, Mark A. Crowther

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 266–270.

https://doi.org/10.1182/asheducation-2008.1.266

Published: 2008

NARROW

Is there a role for low-dose DOACs as prophylaxis?

Direct oral anticoagulant monitoring: what laboratory tests are available to guide us?

Anticoagulating patients with high-risk acquired thrombophilias

Optimizing quality care for the oral vitamin K antagonists (VKAs)

Management of thrombosis in children and neonates: practical use of anticoagulants in children

Reversing vitamin K antagonists: making the old new again

Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations

The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question

Pros and cons of new oral anticoagulants

Pharmacologic tools to reduce bleeding in surgery

Perioperative management of patients on chronic antithrombotic therapy

Catheter-related thrombosis: lifeline or a pain in the neck?

Warfarin Versus New Agents: Interpreting the Data

Duration of Anticoagulation Therapy for Venous Thromboembolism

Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only